Rigel Pharmaceuticals (NASDAQ: RIGL) shares fell 17.44% to $3.74 in the pre-market trading after the company and AstraZeneca (NYSE: AZN) announced topline results from OSKIRA-2 and OSKIRA-3.
Dollar General (NYSE: DG) dipped 5.36% to $50.68 in the pre-market session. Dollar General reported a 3% rise in its first-quarter profit.
salesforce.com (NYSE: CRM) shares dropped 3.24% to $39.71 in pre-market trading after the company announced its plans to buy ExactTarget (NYSE: ET) for $2.34 billion.
Biogen Idec (NASDAQ: BIIB) dipped 2.36% to $222.02 in the pre-market session. Biogen Idec's trailing-twelve-month ROA is 12.81%.
Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.